biotech in bangalore - reflections on a decade of debate
TRANSCRIPT
Biotechnology in BangaloreReflections on a decade of debate
Ian Scoones STEPS Centre, Institute of Development Studies,
University of Sussex, UK
Bangalore: ‘the knowledge economy capital’
2002: hype and hope
• Rapid economic growth and technology-led industrialisation (notably IT sector)
• Competition between Indian states – and Chief Ministers - for foreign investment
• Bangalore pitched as a ‘knowledge hub’ for biotechnology, linking public and private science
• Substantial political (and economic) backing from State government (Vision Group, policy etc.)
Policy narratives
• From IT to BT…. State support for new investments in biotech industry (mostly small start-ups doing contract research for US/European biotech companies)
• From the Green Revolution to the Gene Revolution…. GM crops (Bt cotton) to help solve the cost constraint problems of agriculture. Joint public-private efforts, including State Ag University, Monsanto etc.
Bangalore and biotech
Examples R and D focus R and D Interactions
Elite science
IISc, NCBS Basic biology US/European universities
Public science
UAS Tissue culture, some transgenics
Contract research for Monsanto
Start up companies
Avesthagen,Metahelix,Strand Genomics
Genomic databases for Marker Assisted Selection
Contract research for seed companies, Monsanto etc.
Established local bio/agri- companies
Rallis, Biocon
Transgenics; seed development; genomics platforms
Internal R and D; limited joint research
TNCs Monsanto Transgenics; Pest management and cotton
Internal company interactions; contracting out
Innovation and development
• Excellence model
• Cluster and hub model
• Public private partnerships model
2002-12 - Six challenges to the vision
Science
• New developments (genomics/informatics),• Transgenics hurdles • Few big-hit patents• Revised science-business model
Business
From start-up to emergent majors, through global alliances
2003-04 2010-11Serum Institute Biocon
Biocon Serum Institute
Panacea Biotec Panacea BiotecNovo Nordisk Nuziveedu Seeds
Venkateshwara Hatcheries Reliance Life Sciences
Bharat Serums Quintiles India
Aventis Pharma NovoNordisk
Eli Lilly Co Rasi Seeds
Chiron Behring Vaccines Mayhco
GSK Transasia
Indian Immunologicals Ankur SeedsMayhco Monsanto Syngene International
Novozymes Bharat Biotech
Shanta biotechnics Indian Immunologicals
Wockhardt Krishidan Seeds
Politics
• The state and economic development. • The diminishing influence of the biotech-
science elite?
Poverty and development
• Bt cotton spread, but who benefits? • Inequalities in the new (bio)economy• Inclusive innovation
Civil society action
• Public action and protest• Public interest litigation, court cases and
media
Regulation
• Risk, uncertainty and public disquiet • An acceptance of a more precautionary stance?
The future?4 issues....
• Beyond transgenics• The Mysore model and state capitalism• Inclusive innovation – S and T for
development• Publics, precaution and regulation